Part Details | CIDOFOVIR,INJECTION
6505-01-501-0628
Alternate Parts: 021677, 02-1677, VISTIDE, NDC61958010101, NDC61958-0101-01, 6505-01-501-0628, 01-501-0628, 6505015010628, 015010628
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-501-0628
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| 02-1677 | 89875 | DEFENSE LOGISTICS AGENCYDIRECTORATE OF MEDICAL MATERIEL |
| VISTIDE | 0SFJ8 | GILEAD SCIENCES, INC. |
| NDC61958-0101-01 | 0SFJ8 | GILEAD SCIENCES, INC. |
Technical Data | NSN 6505-01-501-0628
| Characteristic | Specifications |
|---|---|
| SPECIAL FEATURES | SUPPLIED IN A CLEAR GLASS VIAL, EACH CONTAINING 375 MG OF ANHYDROUS CIDOFOVIR IN 5 ML AQUEOUS SOLUTION AT A CONCENTRAION OF 75 MG/ML; STERILE; SINGLE DOSE VIAL; PRESERVATIVE FREE; INTRAVENOUS USE ONLY; STORE AT CONTROLLED ROOM TEMPERATURE 20 TO 25 DEGREE C (68 TO 77 DEGREES F) |
| AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER | 081800 |
| END ITEM IDENTIFICATION | FOR THE TREATMENT OF CYTOMEGALOVIRUS (CMV) RETINITIS IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYDROME (AIDS) |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | CIDOFOVIR INJECTION 375MG ANHYDROUS 5ML AQUEOUS CONCENTRATION 75MG/MLVIAL |